1.
Simpson E, Eichenfield L, Gooderham M, Gonzalez ME, Hebert A, Papp K, Prajapati VH, Krupa D, Burnett P, Berk D, Higham R. Efficacy and Safety of Roflumilast Cream 0.15% in Adults and Children Aged ≥6 Years With Mild to Moderate Atopic Dermatitis in Two Phase 3 Trials (INTEGUMENT-1 and INTEGUMENT-2). J of Skin [Internet]. 2023 Jul. 17 [cited 2024 Jul. 3];7(4):s220. Available from: https://jofskin.org/33014/index.php/skin/article/view/2195